Indications and uses
Helps prevent sunburn.
ESIKA Extreme Moisturizing SPF 16
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2013-12-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:38:33
Label at a glance#
ProductESIKA Extreme Moisturizing SPF 16 (BORGONA SEXY) - BROWN
Active ingredientOctinoxate, Oxybenzone
Label structure29 sections
Dosage and administration
Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor
Storage and handling
Protect the product in this container from excessive heat and direct sun. Apply lipstick following the curves of natural lip line. For added definition, use with a lip penCIl.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active Ingredients | Purpose |
|---|---|
| Octinoxate 6.6% | Sunscreen |
| Oxybenzone 1.5 % | Sunscreen |
Uses
- Helps prevent sunburn.
Warnings
SPL UNCLASSIFIED SECTION
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
SPL UNCLASSIFIED SECTION
- For external use only.
OTC - DO NOT USE SECTION
- Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 hours
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor
Other information
- Protect the product in this container from excessive heat and direct sun.
- Apply lipstick following the curves of natural lip line. For added definition, use with a lip penCIl.
Inactive ingredients
Dipentaerythrityl hexacaprylate/hexacaprate, tridecyl trimellitate, ethylhexyl palmitate, ozokerite, polyethylene, polymethyl methacrylate,water, polyglyceryl-3 diisostearate, tridecyl stearate, copernicia cerifera (carnauba) wax, glycerin, neopentyl glycol dicaprylate/dicaprate, kaolin, octyldodecanol, phenoxyethanol, sodium starch octenylsuccinate, tocopheryl acetate, microcrystalline wax, fragrance, methylparaben, petrolatum, phospholipids, propylparaben, cholesterol, butyrospermum parkii (shea) butter, glycine soja (soybean) oil, butylparaben, ethylparaben, bht,euphorbia cerifera (candelilla) wax, beeswax, cetearyl alcohol, cetearyl glucoside, polyglyceryl-2 dipolyhydroxystearate, isobutylparaben, tocopherol, glycosphingolipids, magnesium chloride, potassium chloride, hydrated silica, sodium chloride.
May contain: red 7 lake , mica, iron oxides, titanium dioxide, bismuth oxychloride, iron oxides, red 21 lake, yellow 5 lake, iron oxides, red 27 lake , talc, blue 1 lake, chitosan, carmine.
SPL UNCLASSIFIED SECTION
PR: Distributed by Ventura Corporation, Ltd. San Juan, Puerto Rico 00926.
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Borgona Sexy - Brown
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Café Moca - Brown
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Coral Chic - Pink
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Fucsia Cautivante - Purple
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Fucsia Glam - Purple
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Granate Seductor - Purple
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Magenta Traviesa - Purple
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Marron Glamour - Brown
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Morado Exuberante - Purple
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Naranja Primavera - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rojo Deseo - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rojo Intrigante - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rojo Lujuria - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rosa Diva - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rosa Encanto - Pink
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rosa Esplendor - Pink
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rosa Romántica - Pink
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Cereza Hechizo - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Frambuesa Manía - Red
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Rosa Dulzura - Pink
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
PRINCIPAL DISPLAY PANEL - 4 g Tube Box - Pimienta Caliente - Brown
ēsika
Extreme
Moisturizing Lipstick
SPF 16
Net Weight 0.14 oz. (4 g)
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| aluminum oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| bismuth oxychloride | INACTIVE INGREDIENT | 4ZR792I587 | 1 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| candelilla wax | INACTIVE INGREDIENT | WL0328HX19 | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| cetearyl glucoside | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| cetostearyl alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| cholesterol | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| d&c red no. 21 | INACTIVE INGREDIENT | 08744Z6JNY | 1 | |
| d&c red no. 27 | INACTIVE INGREDIENT | 2LRS185U6K | 1 | |
| d&c red no. 7 | INACTIVE INGREDIENT | ECW0LZ41X8 | 1 | |
| Dipentaerythrityl hexacaprylate/hexacaprate | INACTIVE INGREDIENT | 554N82UWVW | 1 | |
| ethylhexyl palmitate | INACTIVE INGREDIENT | 2865993309 | 1 | |
| ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| fd&c blue no. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| fd&c yellow no. 5 | INACTIVE INGREDIENT | I753WB2F1M | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| hydrated silica | INACTIVE INGREDIENT | Y6O7T4G8P9 | 1 | |
| isobutylparaben | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| kaolin | INACTIVE INGREDIENT | 24H4NWX5CO | 1 | |
| magnesium chloride | INACTIVE INGREDIENT | 02F3473H9O | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| microcrystalline wax | INACTIVE INGREDIENT | XOF597Q3KY | 1 | |
| neopentyl glycol dicaprylate/dicaprate | INACTIVE INGREDIENT | VLW429K27K | 1 | |
| octyldodecanol | INACTIVE INGREDIENT | 461N1O614Y | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| polyglyceryl-2 dipolyhydroxystearate | INACTIVE INGREDIENT | 9229XJ4V12 | 1 | |
| polyglyceryl-3 diisostearate | INACTIVE INGREDIENT | 46P231IQV8 | 1 | |
| potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| shea butter | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| soybean oil | INACTIVE INGREDIENT | 241ATL177A | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| tridecyl stearate | INACTIVE INGREDIENT | A8OE252M6L | 1 | |
| tridecyl trimellitate | INACTIVE INGREDIENT | FY36J270ES | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- ESIKA Extreme Moisturizing SPF 16 (BORGONA SEXY) - BROWN
- Octinoxate and Oxybenzone
- Octinoxate
- Oxybenzone
- Dipentaerythrityl hexacaprylate/hexacaprate
- tridecyl trimellitate
- ethylhexyl palmitate
- high density polyethylene
- water
- polyglyceryl-3 diisostearate
- tridecyl stearate
- carnauba wax
- glycerin
- neopentyl glycol dicaprylate/dicaprate
- kaolin
- octyldodecanol
- phenoxyethanol
- .alpha.-tocopherol acetate
- microcrystalline wax
- methylparaben
- petrolatum
- propylparaben
- cholesterol
- shea butter
- soybean oil
- butylparaben
- ethylparaben
- butylated hydroxytoluene
- candelilla wax
- yellow wax
- cetostearyl alcohol
- cetearyl glucoside
- polyglyceryl-2 dipolyhydroxystearate
- isobutylparaben
- tocopherol
- magnesium chloride
- potassium chloride
- hydrated silica
- sodium chloride
- d&c red no. 7
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | GEL / VAGINAL | 8 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | PASTE, DENTIFRICE / DENTAL | 0.05 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERINEURAL | 648 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBCUTANEOUS | 1486 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INTRAVENOUS | 1 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| d&c red no. 7 | D&C RED NO. 7 | ECW0LZ41X8 | TABLET, COATED / ORAL | NA | ||
| fd&c blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, LIQUID FILLED / ORAL | 0.08 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, DELAYED RELEASE / ORAL | 230 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | CREAM / VAGINAL | 0.3 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | GEL / VAGINAL | 2 mg | ||
| fd&c blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SYRUP / ORAL | 0.05 mg/5ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| aluminum oxide | ALUMINUM OXIDE | LMI26O6933 | SPONGE / TOPICAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SPRAY / TOPICAL | 0.2 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / NASAL | 250 mg | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | TABLET / ORAL | 3.22 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / TOPICAL | NA | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INFILTRATION | 0.3 mg | ||
| fd&c yellow no. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | SYRUP / ORAL | 0.1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL / TOPICAL | 8 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| d&c red no. 7 | D&C RED NO. 7 | ECW0LZ41X8 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 0.4 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION, EXTENDED RELEASE / ORAL | 4 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SUSPENSION / ORAL | 113 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| d&c red no. 7 | D&C RED NO. 7 | ECW0LZ41X8 | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / ORAL | 2 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | IMPLANT / SUBCUTANEOUS | 77 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRA-ARTERIAL | 278 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, SUGAR COATED / ORAL | NA | ||
| microcrystalline wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CREAM / VAGINAL | 23 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / TOPICAL | 24 mg | ||
| sodium chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2f0cc149-94c9-ef9a-e063-6394a90a579e | 940d673e-1002-4e0e-85d6-1b974dfe0e3d | 2025-02-26 | Warnings | 940d673e-1002-4e0e-85d6-1b974dfe0e3d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.